GlassScriptPhysician profile
Kendra Newman
NPI 1356035406
$1,246.19
in general payments reported to CMS, 2019-2025
22 companies · $633 in 2025
The $633 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $84.03 · 2024: $529 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,246.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $170.06 | 2024-2025 | |
| Boston Scientific Corporation | $154.63 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.97 | 2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $132.19 | 2025 | Amvuttra |
| Medtronic, INC. | $108.10 | 2025 | Linq II |
| Amgen INC. | $96.35 | 2024-2025 | Repatha, Otezla |
| Janssen Pharmaceuticals, INC | $60.13 | 2024 | Xarelto, Spravato |
| Astrazeneca Pharmaceuticals LP | $59.77 | 2023-2024 | Farxiga |
| Astellas Pharma US INC | $41.12 | 2023-2024 | Veozah |
| Heartflow, INC. | $37.45 | 2024-2025 | |
| Amarin Pharma, INC. | $35.91 | 2024 | |
| Bridgebio Pharma, INC. | $34.22 | 2025 | Attruby |
| Idorsia Pharmaceuticals US INC | $32.31 | 2023-2024 | Quviviq |
| Cleerly, INC. | $20.94 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Merck Sharp & Dohme LLC | $19.31 | 2024 | Verquvo |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $18.26 | 2025 | Barostim Neo System |
| Exeltis, USA INC. | $17.11 | 2023 | Slynd |
| Exact Sciences Corporation | $15.62 | 2024 | Cologuard Collection Kit |
| Currax Pharmaceuticals LLC | $14.93 | 2024 | Contrave |
| Pfizer INC. | $14.37 | 2023 | |
| Abbvie INC. | $14.00 | 2024 | |
| Lilly USA, LLC | $13.44 | 2024 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.